Prognostic value of NT-proBNP levels in patients undergoing permanent pacemaker implantation

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 4, 2010, Pages 120-126

  Iwańska, Katarzyna ^a   Gworys, Przemysław ^a   Gawor, Zenon ^a  

^a M Kopernik Hospital   (Poland)

Author keywords

Cardiovascular events; Heart failure; Implantable cardiac pacemaker; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART STIMULATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 77952793399     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.903     Document Type: Article

References (22)

1. Cieśliński A, Dubiel J, Górny J, et al. [The state of cardiological care in Poland. Summary of 2005 report by province advisors in cardiology]. Kardiol Pol. 2005; 63: 693-701. Polish.
2. Sun T, Wang L, Zhang Y. Prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. Arch Med Res. 2006; 37: 502-505.
3. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350: 655-663. (Pubitemid 38364624)
4. Koç M, Bozkurt A, Yildiray-Sahin D, et al. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Cardiol J. 2009; 16: 43-49.
5. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000; 342: 1385-1391.
6. Paxinos G, Katritsis D, Kakouros S, et al. Long-term effect of VVI pacing on atrial and ventricular function in patients with sick sinus syndrome. Pacing Clin Electrophysiol. 1998; 21: 728-734. (Pubitemid 28196995)
7. Kasprzak J, Hoffman R Płońska E, et al. [Echocardiography in clinical practice-Echocardiography Standards Section Polish Cardiology Society 2007]. Kardiol Pol. 2007; 65: 1142-1162. Polish.
8. Sudoh T, Minamino N, Kangawa K, Matsuo H. Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun. 1988; 155: 726-732.
9. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
10. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26: 384-416. (Pubitemid 40283098)
11. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005; 46: e1-e82.
12. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007; 50: 2357-2368.
13. Ciuraszkiewicz K, Janion M, Sielski J, et al. Post-myocardial infarction intraventricular conduction defects and B-type natriuretic peptide levels. Clin Cardiol. 2009; 32: E12-E17.
14. Ciuraszkiewicz K, Janion M, Dudek D, Gawor Z. Plasma B-type natriuretic peptide as a marker of myocardial asynchrony. Cardiology. 2009; 113: 193-197.
15. Thackray SD, Witte K, Ghosh J, et al. N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population. Eur Heart J. 2006; 27: 447-453. (Pubitemid 43209170)
16. Jeli'c V, Milasinovi'c G, Pavlovi'c SU, et al. [Brain natriuretic peptide as a predictor of heart failure in patients with permanent pacemaker]. Srp Arh Celok Lek. 2007; 135: 21-25. Serbian.
17. Horie H, Tsutamoto T, Minai K, et al. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J. 2000; 64: 965-970.
18. Sielski J, Janion M, Gawor Z, et al. Correlation analysis of atrial natriuretic peptide concentration, echocardiography left atrial and left ventricular dimensions, and renal function parameters in patients after permanent pacemaker implantation. Cardiol J. 2009; 16: 157-163.
19. Saccomanno G, Fraticelli A, Marini M, et al. Permanent ventricular and dual chamber cardiac stimulation: role of pacing mode in relation to chronic atrial fibrillation risk and stroke development Arch Gerontol Geriatr. 1999; 29: 61-74.
20. Wu X, Seino Y, Ogura H et al. Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation. Jpn Heart J. 2001; 42: 471-482. (Pubitemid 33040837)
21. Ichiki H, Oketani N, Hamasaki S, et al. Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker. Pacing Clin Electrophysiol. 2006; 29: 985-990.
22. Wang RX, Quo T, Li XR. BNP/NT-proBNP and cardiac pacing: a review. Pacing Clin Electrophysiol. 2009; 32: 794-799.